Anna Naumovich
Internal Medicine · St Louis, MONPI 1669542668
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 380 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AstraZeneca at 27.5% of the total. Reporting peaked in 2019 at $3,446 and has fallen 71.8% since, to $972 in 2023. Among internal medicine clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 380 payments — averaging $22.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Novo Nordisk$2K
- Lilly USA, LLC$953
- Sunovion Pharmaceuticals Inc.$565
- Johnson & Johnson$451
- AbbVie$372
- plus $2K from 18 others
What the payments were for
- Food & beverage$8,716100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 82 | $2,396 |
| Novo Nordisk | 100 | $1,940 |
| Lilly USA, LLC | 51 | $953 |
| Sunovion Pharmaceuticals Inc. | 37 | $565 |
| Johnson & Johnson | 10 | $451 |
| AbbVie(2 entities) | 11 | $372 |
| GSK | 3 | $369 |
| Merck | 17 | $297 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $197 |
| Arbor Pharmaceuticals, Inc. | 13 | $187 |
| Sanofi-aventis U.S. LLC | 9 | $167 |
| Abbott | 7 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $131 |
| Bayer | 1 | $122 |
| Vanda Pharmaceuticals Inc. | 4 | $120 |
| Pfizer | 5 | $82 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $65 |
| Novartis | 3 | $55 |
| Avanir Pharmaceuticals, Inc. | 1 | $28 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $16 |
| Eisai Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,716 in reported general payments places this provider in the 90th percentile of 2,097 internal medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Simvastatin | 13 | $64 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in St Louis
- David ParksSt Louis$50K
- Patrick McCannSt Louis$22K
- Timothy SmithSaint Peters$428K
- Craig DietzKansas City$226K
- Kevin SuttmoellerKansas City$198K
- Vinay KamatSaint Louis$191K
- David PrelutskySaint Louis$182K
- Dima DandachiColumbia$157K
- Justin SteinkampSaint Charles$139K
- Tracy NorfleetSaint Louis$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.